By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087



Company News
Aerie (AERI) Announces Appointment Of Isabel Moredo, PharmD, As Eastern Regional Director Of Medical Science Liaisons 8/14/2017 6:57:22 AM
Aerie (AERI) Reports Second Quarter 2017 Financial Results And Provides Business Update 8/2/2017 8:19:03 AM
Aerie (AERI) To Present At The Canaccord Genuity Growth Conference 8/2/2017 8:03:18 AM
Aerie (AERI) Enters Into Collaboration Agreement With DSM Focused On Technology To Potentially Deliver Aerie Compounds To Treat Retinal Diseases Such As Wet AMD 7/31/2017 6:58:53 AM
Aerie (AERI) To Announce Second Quarter 2017 Financial Results And Host Conference Call On Tuesday, August 1, 2017 7/26/2017 6:20:50 AM
Aerie (AERI) Reports Positive Roclatan™ (Netarsudil/Latanoprost Ophthalmic Solution) 0.02%/0.005% Phase III 12-Month Topline Safety Results 7/20/2017 11:05:35 AM
Aerie (AERI) Announces Public Offering Of Common Stock 5/26/2017 6:29:00 AM
Aerie (AERI) Raises $125 Million In ATM Sales And Upsized Follow-On Offering 5/26/2017 6:03:48 AM
Aerie (AERI) Rockets as Eye Drug Wows in Key Phase III Study 5/25/2017 5:38:10 AM
Aerie (AERI) Announces New Hires 5/16/2017 8:19:27 AM